| Tag | Content |
|---|
EnhancerAtlas ID | HS127-06758 |
Organism | Homo sapiens |
Tissue/cell | Macrophage |
Coordinate | chr12:8203220-8205350 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Foxd3 | MA0041.1 | chr12:8204463-8204475 | GTTTGTTTGTTT | + | 6.32 | | ZNF263 | MA0528.1 | chr12:8203495-8203516 | CCCTTCCCTTCCCTTTCCTTC | - | 6.03 | | ZNF263 | MA0528.1 | chr12:8203581-8203602 | CCCTTCCCTTCCCTTTCCTTC | - | 6.03 | | ZNF263 | MA0528.1 | chr12:8203613-8203634 | CCCTTCCCTTCCCTTTCCTTC | - | 6.03 | | ZNF263 | MA0528.1 | chr12:8203622-8203643 | TCCCTTTCCTTCCCCTTCCCC | - | 6.03 | | ZNF263 | MA0528.1 | chr12:8203408-8203429 | GTCCCCTCCCCTCCCTTCCCC | - | 6.07 | | ZNF263 | MA0528.1 | chr12:8203533-8203554 | CCCTTCCCTTCCCCTTCCTTT | - | 6.25 | | ZNF263 | MA0528.1 | chr12:8203498-8203519 | TTCCCTTCCCTTTCCTTCCCC | - | 6.26 | | ZNF263 | MA0528.1 | chr12:8203584-8203605 | TTCCCTTCCCTTTCCTTCCCC | - | 6.26 | | ZNF263 | MA0528.1 | chr12:8203616-8203637 | TTCCCTTCCCTTTCCTTCCCC | - | 6.26 | | ZNF263 | MA0528.1 | chr12:8203414-8203435 | TCCCCTCCCTTCCCCTCCCTT | - | 6.46 | | ZNF263 | MA0528.1 | chr12:8203444-8203465 | TCCCCTTCCCTTCCCTTCCCC | - | 6.51 | | ZNF263 | MA0528.1 | chr12:8203563-8203584 | TTCCCCTCCCTTCCCTTCCCC | - | 6.53 | | ZNF263 | MA0528.1 | chr12:8203541-8203562 | TTCCCCTTCCTTTCCTCTTCC | - | 6.58 | | ZNF263 | MA0528.1 | chr12:8203516-8203537 | CCCTTCCCTTCCCCTTCCCCT | - | 6 | | ZNF263 | MA0528.1 | chr12:8203683-8203704 | CCCTTCCCTTCCCCTTCCCCT | - | 6 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_09657 | chr12:8199957-8208551 | CD14 | | SE_53794 | chr12:8202823-8203458 | Spleen | | SE_53794 | chr12:8203540-8204555 | Spleen | | SE_53794 | chr12:8204846-8206214 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH12I008047 | chr12 | 8199958 | 8208551 |
|
Enhancer Sequence | GAGCTAAGAA GCTTGTTTCA AAACCGTTGT ACTCTGATGA GTTGCTTTGC TTTCCTTTGA 60
CTCTGAGCTG GCATTCTGTG CATTTTTGCC TGCATCTCGC TGGAGGGAAT GAGCCTTTAT 120
AATTCCCAAG GCTGGAGGAT GGGTTACCTG CTAAGAAGGT GTGTGTCGGG GAGACTAACG 180
AAGACAGTGT CCCCTCCCCT CCCTTCCCCT CCCTTCCTTT CCCTTCCCCT TCCCTTCCCT 240
TCCCCTTCCC TTCCCCTTCC CTTCCCCTTC CCTTCCCCTT CCCTTCCCTT TCCTTCCCCT 300
TCCCTTCCCC TTCCCCTTCC CTTCCCCTTC CTTTCCTCTT CCCTTCCCCT CCCTTCCCTT 360
CCCCTTCCCT TCCCTTTCCT TCCCCTTCCC TTTCCCTTCC CTTCCCTTTC CTTCCCCTTC 420
CCCTTCCCTT GCCCTTCCTT TCCCCTTCCC TTCCATTCCC TTTCCCTTCC CTTCCCCTTC 480
CCCTTCCCTT CCCTTCCCTT TCCCTTCCCC TTTTCTTTTC TTTTCAACAG AGTCTCGCTC 540
TGTTGCCCAG GCTGGAGTAC AGTGGTGCGA TCTCAGCTCA CTACAACCTC CACCTCCTGG 600
GTTGAAATGA TTCTCCTGCT TGAGCCTCTC AACTAGCTGG GACTACAGAC CCACACCACC 660
ATGCCTGGCT AATTTTTGTA TTTTTAGTAG AGACGGGGTT TTGCCATGTT GGCTAGGCTT 720
GTCTTGAACT CCTGACCACA AGTGATCCAC CTGCCTCTGC CTCCCAAAGT GCTGGGATTA 780
CAGGCGTGAT CCACTGGCCC CGGCTAGATG TACTTTAAAA TTAGCAACTG CAATAGTAAA 840
AGGAAGTGAA AGCATACATA TAAGCAAAAG ATAGCTATGT GCAACATTTT TGTGTGGCTT 900
TGGAATCTAG ATGGAAGATG TGCTCAGGCA AATAAAATGA ATTTGTTATC CACACATACT 960
TGCTGTGTGC CCATGTCTGC TTTCCTGTCA CCTGATCTCT AGAATCAGGG GTCTGGGACT 1020
GAAGTATCTC TGATAGTGGG GGTGGGGCAG GGAGACACTA AATTGCCACA GACAGAACAA 1080
AATGAACAGG TCCTTCACAT TTAGACACAT AGAAAAATCA CTGTTATTCT GCCTAACCAC 1140
ACGTGTTTTC AATTTTGGGG GTGACATCTG ACTCTCTCTA TTCTTTGTCC ATATAATATA 1200
AATACAGATT TCTATACTGC TATTTCATGT GATATTATCT TCTGTTTGTT TGTTTGAGTC 1260
AGAGTCTTTT TCTGTTGCCC AGGCTGGAGT GCAGTAGGCA ATGGTGTGAT CCTGGCTCAC 1320
TGCAACCTCC GCCTCCCAGG TTCAAGTGAT TCTCGAGCCT CAGCCTCCCG AGCAGCTGGG 1380
ATCACAGGCG CCCGCCACTG TGCCTGGCTA ATTTTTATTT TTTAGTAGAG ACAGGGTTTC 1440
ACCATGTTGG CCAGTCTGGT CTAGAACTCC TGACCTCAAG TGATCCACCC ATCTCGGCCT 1500
CTCAAAGTGC TGGGATTATA GGCATGAGCC ACCACGCCCA GCCATATGAT ATTATCTTCT 1560
GTATGTTATT TTATCATTAT CATATGTTTT CAGAAGTACA ATTTTTTTTT TTTTTTGAGA 1620
CGGAGTCTCG CTCTATCGCC CAGGCTGGAG TGCAATGGCA CGGTCTTAGC TCACTGCAAG 1680
ACCTCCCGGG TTCATGCCAT TCTCCTGCTT CAGCCTCCCG AGTAGCTGGG ACTACAGGCA 1740
CATGTGACCA CACCCAGCTA ATTTTTTGAG TTTTTAGTAG AGATGGGGTT TCTCCATGTT 1800
GGCCAGGCTG GTCTCGAATT CCTGACCTCG TGATCCGCCT GCCTTGGCCT CCCAAAGTGC 1860
TGGGATAACA AGTGTGAGCA ACTGTGCCTG GCGTCAGAAG TATAATTGTT AATGGCAGCA 1920
TAATATTTAA TTGCTGTGGA ATGTAATTTA CTCTAGTTTA TTTCCTGAGA CCTCACTGAA 1980
ATGGTGACCT GCAACCAAAA TTAACTCCAG CTGATAAGGG CGATAGCCTC ACAAGGCCTT 2040
CTTCGTGGTG TTATCTGGGG CTGAGCACTG TCCTTGTAAA TTGAGGGAAC AGCTTCCCAT 2100
CCACTCTCCT TTTACTCTCT TTCTTTCTTT 2130
|
